Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Spine (Phila Pa 1976) ; 17(6 Suppl): S172-5, 1992 Jun.
Article in English | MEDLINE | ID: mdl-1385902

ABSTRACT

A prospective, randomized, double-blind study was performed to evaluate the clinical efficacy of intradiscal steroid injections. Criteria for entrance were one-level internal disc disruption or nonsequestered nuclear prolapse with or without sciatica and a positive pain response on awake discography. Exclusion criteria were multilevel disease, central or lateral stenosis, prior lumbar surgery, or medical disease requiring systemic steroids. A total of 25 patients were randomly assigned to Treatment Group A (methylprednisolone, Depo-Medrol 80 mg/ml, The Upjohn Co., Kalamazoo, Michigan) or Treatment Group B (bupivacaine, Marcaine .5% 1.5 ml, Sanofi Winthrop Pharmaceuticals, New York, New York). Fourteen patients received Depo-Medrol, with 21% showing subjective improvement and 79% no improvement; 0% were clinically worse. Eleven patients received intradiscal Marcaine, with 9% showing clinical improvement and 91% no improvement; 0% were clinically worse. To quantify clinical response, a pain diagram grid score, a visual analog scale, and the Oswestry Pain Questionnaire were used before injection and 10-14 days after injection. No statistically significant benefit was identified in the use of intradiscal steroids.


Subject(s)
Anti-Inflammatory Agents/therapeutic use , Intervertebral Disc Displacement/drug therapy , Methylprednisolone/analogs & derivatives , Adult , Anti-Inflammatory Agents/administration & dosage , Back Pain/diagnosis , Bupivacaine/administration & dosage , Bupivacaine/therapeutic use , Double-Blind Method , Humans , Methylprednisolone/administration & dosage , Methylprednisolone/therapeutic use , Methylprednisolone Acetate , Pain Measurement , Prospective Studies
2.
Spine (Phila Pa 1976) ; 16(6 Suppl): S216-21, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1830702

ABSTRACT

This study was undertaken to determine the correlation between awake discography findings and magnetic resonance imaging in the evaluation of symptomatic lumbar disc disease. The study included 164 consecutive patients who underwent evaluation with discography and magnetic resonance imaging for lumbar disc disease from August 1987 to September 1989. Chronic low-back pain, with or without radicular symptoms, was the presenting complaint in each case. Each patient had previously failed conservative treatment. The average age was 36 (range, 19-66 years). Magnetic resonance images were performed before discography in each case. Discography was performed with patients minimally sedated and under local anesthesia. A lateral approach was used. Magnetic resonance imaging and discography correlated in 90 cases (55%) and differed in 74 (45%). Considering disc levels, discography and magnetic resonance imaging correlated in 371 discs (80%). There were 172 normal discs and 199 abnormal discs. Of the abnormal discs, 151 (76%) reproduced symptoms. In 60 discs (13%), magnetic resonance images showed abnormal findings and the discogram normal findings. Discs levels classified as abnormal on magnetic resonance imaging demonstrated that 108 discs (37%) were asymptomatic. Magnetic resonance imaging showed normal findings and the discogram abnormal findings in 34 discs (7%), of which 21 (5%) recreated exact symptoms and 13 (2%) caused no pain. Magnetic resonance imaging is a static test and discography the only available dynamic test for disc evaluation. Awake discography is a diagnostic study that can determine which abnormal discs are symptomatic via the pain response.


Subject(s)
Intervertebral Disc Displacement/diagnosis , Intervertebral Disc/pathology , Lumbar Vertebrae/pathology , Magnetic Resonance Imaging , Adult , Back Pain/diagnosis , Back Pain/diagnostic imaging , Consciousness , Female , Humans , Intervertebral Disc/diagnostic imaging , Intervertebral Disc Displacement/diagnostic imaging , Male , Radiography
3.
Spine (Phila Pa 1976) ; 15(7): 716-7, 1990 Jul.
Article in English | MEDLINE | ID: mdl-2145645

ABSTRACT

Colchicine, a drug used for centuries in the treatment of gout, has been reported to be effective for low-back pain due to disc disorders. A prospective, randomized, double-blind study evaluating the therapeutic effect of intravenous colchicine was conducted in a group of patients with low-back pain with symptoms originating less than 6 months previously. Each patient completed a questionnaire and a pain drawing. Laboratory studies including uric acid and sedimentation rate were performed, as was a detailed physical examination and lumbar thermography. All treatment parameters (including physical therapy, anti-inflammatory medications, and instructions) were constant except that each patient received either intravenous colchicine or intravenous saline. Results indicate a significant difference between the two groups, the intravenous colchicine group showing improvement in symptoms for a few hours or days over a 3-week course of treatment. However, the relief was often of short duration.


Subject(s)
Back Pain/drug therapy , Colchicine/therapeutic use , Adult , Colchicine/administration & dosage , Double-Blind Method , Female , Humans , Infusions, Intravenous , Male , Prospective Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...